Skip to main content
SpringerLink
Log in

Classification and Staging of Myelodysplastic Syndromes

  • Chapter
Hematologic Malignancies: Myelodysplastic Syndromes

Part of the book series: Hematologic Malignancies ((HEMATOLOGIC))

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 139.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Argyle JC, Benjamin DR, Lampkin B, Hammond D (1989) Acute nonlym-phocytic leukemias of childhood. Inter-observer variability and problems in the use of the FAB classification. Cancer 63:295–301

    PubMed  CAS  Google Scholar 

  • Aul C, Gattermann N, Heyll A, Germing U, Derigs G, Schneider W (1992) Primary myelodysplastic syndromes: analysis of prognostic factors in 235 patients and proposals for an improved scoring system. Leukemia 6:52–59

    PubMed  CAS  Google Scholar 

  • Bennett JM (2003) Morphologic dysplasia in acute myeloid leukemia: importance of granulocytic dysplasia. (Comment). J Clin Oncol 21:3004–3005

    PubMed  Google Scholar 

  • Bennett JM, Begg CB (1981) Eastern Cooperative Oncology Group study of the cytochemistry of adult acute myeloid leukemia by correlation of subtypes with response and survival. Cancer Res 41:4833–4837

    PubMed  CAS  Google Scholar 

  • Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, Sultan C (1976) Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group. Br J Haematol 33:451–458

    PubMed  CAS  Google Scholar 

  • Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick HR, Sultan C, The French-American-British (FAB) Co-Operative Group (1982) Proposals for the classification of the myelodysplastic syndromes. Br J Haematol 51:189–199

    PubMed  CAS  Google Scholar 

  • Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick H, Sultan C, Cox C (1994) The chronic myeloid leukaemias: guidelines for distinguishing chronic granulocytic, atypical chronic myeloid, and chronic myelomonocytic leukaemia. Proposals by the French-American-British Cooperative Leukaemia Group. Br J Haematol 87:746–754

    PubMed  CAS  Google Scholar 

  • Bennett JM, Cassileth PA, Paietta E, Rowe JM, Wiernik PH (1996) Morphologic classification of acute myeloid leukemia: concordance among Eastern Cooperative Oncology Group investigators: a comment. Leukemia 10:13–65

    Google Scholar 

  • Borowitz MJ, Guenther KL, Shults KE, Stelzer GT (1993) Immunopheno-typing of acute leukemia by flow cytometric analysis. Use of CD45 and right-angle light scatter to gate on leukemic blasts in three-color analysis. Am J Clin Pathol 100:534–540

    PubMed  CAS  Google Scholar 

  • Browman GR Neame PB, Soamboonsrup P (1986) The contribution of cytochemistry and immunophenotyping to the reproducibility of the FAB classification in acute leukemia. Blood 68:900–905

    PubMed  CAS  Google Scholar 

  • Castoldi GL, Liso V, Fenu S, Vegna ML, Mandelli F (1993) Reproducibility of the morphological diagnostic criteria for acute myeloid leukemia: the GIMEMA group experience. Ann Hematol 66:171–174

    Article  PubMed  CAS  Google Scholar 

  • Cermak J, Michalova K, Brezinova J, Zemanova Z (2003) A prognostic impact of separation of refractory cytopenia with multilineage dysplasia and 5q-syndrome from refractory anemia in primary myelodysplastic syndrome. Leuk Res 27:221–229

    PubMed  Google Scholar 

  • Cheson BD, Bennett JM, Kopecky KJ, Buchner T, Willman CL, Estey EH, Schiffer CA, Doehner H, Tallman MS, Lister TA, Lo-Coco F, Willemze R, Biondi A, Hiddemann W, Larson RA, Lowenberg B, Sanz MA, Head DR, Ohno R, Bloomfield CD, LoCocco F, International Working Group for Diagnosis SoRCTOaRSfTTiAML (2003) Revised recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia. J Clin Oncol 21:4642–4649

    Article  PubMed  Google Scholar 

  • Chudgar U, Khanduri U (1992) Intraobserver and interobserver reproducibility of the FAB classification in acute leukaemia. Indian J Pathol Microbiol 35:229–236

    PubMed  CAS  Google Scholar 

  • Germing U, Gattermann N, Strupp C, Aivado M, Aul C (2000) Validation of the WHO proposals for a new classification of primary myelodysplastic syndromes: a retrospective analysis of 1600 patients. Leuk Res 24:983–992

    Article  PubMed  CAS  Google Scholar 

  • Goasguen JE, Matsuo T, Cox C, Bennett JM (1992) Evaluation of the dysmyelopoiesis in 336 patients with de novo acute myeloid leukemia: major importance of dysgranulopoiesis for remission and survival. Leukemia 6:520–525

    PubMed  CAS  Google Scholar 

  • Greenberg P, Cox C, LeBeau MM, Fenaux P, Morel P, Sanz G, Sanz M, Vallespi T, Hamblin T, Oscier D, Ohyashiki K, Toyama K, Aul C, Mufti G, Bennett J (1997) International scoring system for evaluating prognosis in myelodysplastic syndromes (published erratum appears in Blood 1998; 91:1100). Blood 89:2079–2088

    PubMed  CAS  Google Scholar 

  • Haferlach T, Schoch C (2002) Modern techniques in leukemia diagnosis (Review) [German]. Internist 43:1190–1196

    Article  PubMed  CAS  Google Scholar 

  • Haferlach T, Kohlmann A, Kern W, Hiddemann W, Schnittger S, Schoch C (2003) Gene expression profiling as a tool for the diagnosis of acute leukemias (Review). Semin Hematol 40:281–295

    Article  PubMed  CAS  Google Scholar 

  • Haferlach T, Kern W, Kohlmann A, Dugas M, Merk S, Hiddemann W, Schnittger S, Schoch C (2004) MDS and AML are closely related diseases: gene expression patterns reveal clear similarities with respect to karyotypes and are less related to the bone marrow blast percentages [Abstract]. Blood 104:137 a

    Google Scholar 

  • Hofmann WK, de Vos S, Komor M, Hoelzer D, Wachsman W, Koeffler HP (2002) Characterization of gene expression of CD34+ cells from normal and myelodysplastic bone marrow. Blood 100:3553–3560

    PubMed  CAS  Google Scholar 

  • Howe RB, Porwit-MacDonald A, Wanat R, Tehranchi R, Hellstrom-Lindberg E (2004) The WHO classification of MDS does make a difference. Blood 103:3265–3270

    Article  PubMed  CAS  Google Scholar 

  • International Standing Committee on Human Cytogenetic Nomenclature (1995) Mitelman F (ed) An international system for human cytogenetic nomenclature (1995): recommendations of the International Standing Committee on Human Cytogenetic Nomenclature, Memphis, Tennessee, USA, October 913, 1994. Karger, Farmington, CT

    Google Scholar 

  • Jaffe ES, Harris NL, Stein H, Vardiman JW (ed) (2001) World Health Organization classification of tumours. Pathology & genetics: tumours of hematopoietic and lymphoid tissues. IARC Press, Washington, DC

    Google Scholar 

  • Kern W, Danhauser-Riedl S, Ratei R, Schnittger S, Schoch C, Kolb HJ, Ludwig WD, Hiddemann W, Haferlach T (2003a) Detection of minimal residual disease in unselected patients with acute myeloid leukemia using multiparameter flow cytometry for definition of leukemia-associated immunophenotypes and determination of their frequencies in normal bone marrow. Haematologica 88:646–653

    PubMed  Google Scholar 

  • Kern W, Kohlmann A, Wuchter C, Schnittger S, Schoch C, Mergenthaler S, Ratei R, Ludwig WD, Hiddemann W, Haferlach T (2003 b) Correlation of protein expression and gene expression in acute leukemia. Cytometry 55B:29–36

    Article  CAS  Google Scholar 

  • Kohlmann A, Schoch C, Schnittger S, Dugas M, Hiddemann W, Kern W, Haferlach T (2003) Molecular characterization of acute leukemias by use of microarray technology. Genes Chromosomes Cancer 37:396–405

    Article  PubMed  CAS  Google Scholar 

  • Löffler H, Rastetter J, Haferlach T (2005) Atlas of clinical hematology. Springer, Berlin, Heidelberg, New York

    Google Scholar 

  • Ludwig W-D, Haferlach T, Schoch C (2005) Classification of acute leukemias. In: Pui C-H (ed) Treatment of acute leukemias: new directions for clinical research. Humana Press, Totowa, NJ, pp 3–42

    Google Scholar 

  • Miyazato A, Ueno S, Ohmine K, Ueda M, Yoshida K, Yamashita Y, Kaneko T, Mori M, Kirito K, Toshima M, Nakamura Y, Saito K, Kano Y, Furusawa S, Ozawa K, Mano H (2001) Identification of myelodysplastic syndrome-specific genes by DNA microarray analysis with purified hematopoietic stem cell fraction. Blood 98:422–427

    Article  PubMed  CAS  Google Scholar 

  • Morel P, Hebbar M, Lai J-L, Duhamel A, Preudhomme C, Wattel E, Bauters F, Fenaux P (1993) Cytogenetic analysis has strong independent prognostic value in de novo myelodysplastic syndromes and can be incorporated in a new scoring system: a report on 408 cases. Leukemia 7:1315–1323

    PubMed  CAS  Google Scholar 

  • Mufti GJ, Stevens JR, Oscier DG, Hamblin TJ, Machin D (1985) Myelodysplastic syndromes: a scoring system with prognostic significance. Br J Haematol 59:425–433

    PubMed  CAS  Google Scholar 

  • Ogata K, Nakamura K, Yokose N, Tamura H, Tachibana M, Taniguchi O, Iwakiri R, Hayashi T, Sakamaki H, Murai Y, Tohyama K, Tomoyasu S, Nonaka Y, Mori M, Dan K, Yoshida Y (2002) Clinical significance of phenotypic features of blasts in patients with myelodysplastic syndrome. Blood 100:3887–3896

    Article  PubMed  CAS  Google Scholar 

  • Ost A, Lagerlof B, Sundstrom C, Lindstrom P, Gyllenhammer H, Engstedt L, Skoog L (1983) A study of the reproducibility of the diagnostic criteria for acute leukaemia. Scand J Haematol 31:257–266

    PubMed  CAS  Google Scholar 

  • Sales CV, Rojo MJ, Chavez SG, Albisua GLM, Godinez R, Collazo JJ, Gaminio E, Rios D, Dominguez EME, Pizzuto CJ (1991) Agreement among observers in the classification of acute leukemias. [Spanish]. Revista de Investigacion Clinica 43:223–228

    Google Scholar 

  • Sanz GF, Sanz MA, Vallespì T, Cañizo MC, Torrabadella M, Garcìa S, Irriguible D, San Miguel JF (1989) Two regression models and a scoring system for predicting survival and planning treatment in myelodysplastic syndromes: a multivariate analysis of prognostic factors in 370 patients. Blood 74:395–408

    PubMed  CAS  Google Scholar 

  • Schoch C, Kohlmann A, Schnittger S, Brors B, Dugas M, Mergenthaler S, Kern W, Hiddemann W, Eils R, Haferlach T (2002 a) Acute myeloid leukemias with reciprocal rearrangements can be distinguished by specific gene expression profiles. Proc Natl Acad Sci USA 99:10008–10013

    Article  PubMed  CAS  Google Scholar 

  • Schoch C, Schnittger S, Kern W, Lengfelder E, Loffler H, Hiddemann W, Haferlach T (2002 b) Rapid diagnostic approach to PML-RARalpha-positive acute promyelocytic leukemia. Hematol J 3:259–263

    Article  PubMed  CAS  Google Scholar 

  • Schoch C, Schnittger S, Klaus M, Kern W, Hiddemann W, Haferlach T (2003) AML with 11q23/MLL abnormalities as defined by the WHO classification: incidence, partner chromosomes, FAB subtype, age distribution, and prognostic impact in an unselected series of 1897 cytogenetically analyzed AML cases. Blood 102: 2395–2402

    Article  PubMed  CAS  Google Scholar 

  • Stetler-Stevenson M, Arthur DC, Jabbour N, Xie XY, Molldrem J, Barrett AJ, Venzon D, Rick ME (2001) Diagnostic utility of flow cytometric immunophenotyping in myelodysplastic syndrome. Blood 98: 979–987

    Article  PubMed  CAS  Google Scholar 

  • Sultan C, Deregnaucourt J, Ko YW, Imbert M, d’Agay MF, Gouault-Heilmann M, Brun B (1981) Distribution of 250 cases of acute myeloid leukaemia (AML) according to the FAB classification and response to therapy. Br J Haematol 47:545–551

    PubMed  CAS  Google Scholar 

  • Theml H (2004) Color atlas of hematology: practical microscopic and clinical diagnosis. Thieme Medical Publishers, Stuttgart

    Google Scholar 

  • Van Den Berghe H, Michaux L (1997) 5q-, twenty-five years later: a synopsis. (Review). Cancer Genet Cytogenet 94:1–7

    PubMed  Google Scholar 

  • Wells DA, Benesch M, Loken MR, Vallejo C, Myerson D, Leisenring WM, Deeg HJ (2003) Myeloid and monocytic dyspoiesis as determined by flow cytometric scoring in myelodysplastic syndrome correlates with the IPSS and with outcome after hemopoietic stem cell transplantation. Blood 102:394–403

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. MML Munich Leukemia Laboratory, Max-Lebsche-Platz 31, 81377, Munich, Germany

    Torsten Haferlach M. D.

  2. Medical Hospital and Health Center III, Clinical Center of the University of Munich-Grosshadern, Marchioninistrasse 15, 81377, Munich, Germany

    Wolfgang Kern M. D.

Authors
  1. Torsten Haferlach M. D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Wolfgang Kern M. D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Springer Berlin Heidelberg

About this chapter

Cite this chapter

Haferlach, T., Kern, W. (2006). Classification and Staging of Myelodysplastic Syndromes. In: Hematologic Malignancies: Myelodysplastic Syndromes. Hematologic Malignancies. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-30794-X_5

Download citation

  • DOI: https://doi.org/10.1007/3-540-30794-X_5

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-26188-9

  • Online ISBN: 978-3-540-30794-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation